← Evidence map

ArticleCancers2020

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.

Anne Schaefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32325840